Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | September 14, 2023 09:06am

Gainers

  • First Wave BioPharma (NASDAQ:FWBI) stock moved upwards by 108.7% to $0.91 during Thursday's pre-market session. The market value of their outstanding shares is at $6.4 million.
  • Avalo Therapeutics (NASDAQ:AVTX) stock moved upwards by 34.1% to $0.3. The market value of their outstanding shares is at $6.0 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares rose 22.22% to $1.1. The company's market cap stands at $2.2 million.
  • Navidea Biopharmaceutical (AMEX:NAVB) shares moved upwards by 20.6% to $0.14. The market value of their outstanding shares is at $14.0 million.
  • Longeveron Inc. - Subscription Right (NASDAQ:LGVNR) stock rose 14.94% to $0.01.
  • Evoke Pharma (NASDAQ:EVOK) shares increased by 14.85% to $1.16. The company's market cap stands at $3.8 million.

Losers

  • Biolase (NASDAQ:BIOL) stock declined by 46.3% to $1.75 during Thursday's pre-market session. The market value of their outstanding shares is at $1.8 million.
  • Bionomics (NASDAQ:BNOX) stock fell 21.79% to $1.4. The company's market cap stands at $11.4 million.
  • Scinai Immunotherapeutics (NASDAQ:SCNI) shares declined by 16.04% to $1.1. The market value of their outstanding shares is at $4.0 million.
  • Impel Pharmaceuticals (NASDAQ:IMPL) stock decreased by 15.63% to $0.68. The company's market cap stands at $16.0 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) stock fell 13.27% to $0.16. The company's market cap stands at $5.0 million.
  • Petros Pharma (NASDAQ:PTPI) shares declined by 13.14% to $1.72. The market value of their outstanding shares is at $3.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVTX BIOL BNOX EVOK FWBI IMPL LGVNR NAVB PTPI RNAZ SCNI ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist